Log in to save to my catalogue

New Severe Acute Respiratory Syndrome Study Results Reported from Azabu University (Cyclic Phthalate...

New Severe Acute Respiratory Syndrome Study Results Reported from Azabu University (Cyclic Phthalate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A730509706

New Severe Acute Respiratory Syndrome Study Results Reported from Azabu University (Cyclic Phthalate Esters As Liver X Receptor Antagonists With Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties)

About this item

Full title

New Severe Acute Respiratory Syndrome Study Results Reported from Azabu University (Cyclic Phthalate Esters As Liver X Receptor Antagonists With Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties)

Publisher

NewsRX LLC

Journal title

Respiratory Therapeutics Week, 2022, p.3309

Language

English

Publication information

Publisher

NewsRX LLC

More information

Alternative Titles

Full title

New Severe Acute Respiratory Syndrome Study Results Reported from Azabu University (Cyclic Phthalate Esters As Liver X Receptor Antagonists With Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A730509706

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A730509706

Other Identifiers

ISSN

1543-6659

How to access this item